Loading clinical trials...

A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in England | Clinical Trials | Clareo Health

COMPLETED

A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in England

Healthcare Resources Utilization and Associated Costs of Adult ADHD in England

NCT05137704•Takeda

View on ClinicalTrials.gov

Summary

The main aim of the study is to learn about the demographic and clinical characteristics, healthcare resources utilization (HCRU) and costs associated with before and after ADHD diagnosis in England. No study medicines will be provided to participants in this study. The record available in Clinical Practice Research Datalink (CPRD) database and Hospital Episode Statistics (HES) database for ADHD participants will be assessed.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Age greater than or equal to (\>=) 18 years at the beginning of the patient observation period (that is 18-months prior to the adult ADHD diagnosis to ensure they would have been seen in adult health care services).
•2. First record of an adult ADHD diagnosis between 01st January 2016 and 30th June 2018.
•3. Data availability in the database at least during the 18-months before and after the index date.

Exclusion Criteria

•A participant will be excluded from the study if their CPRD linked to HES electronic medical record data includes:
•1. Incomplete information for key demographics (that is, missing age or sex).
•2. Clinical history of a diagnosis of ADHD during childhood or adolescence.
•3. Prescription of a licensed adult ADHD medication (that is, methylphenidate, lisdexamfetamine, dexamfetamine, atomoxetine) during the pre-index period.

Locations (1)

IQVIA Ltd

London, United Kingdom

Key Dates

Start Date

December 1, 2021

Primary Completion Date

March 31, 2022

Completion Date

March 31, 2022

Last Updated

July 12, 2022

Enrollment

2,236

ACTUAL participants

Conditions

Attention Deficit Hyperactivity Disorder (ADHD)

Interventions

No intervention

OTHER

L-theanine and Paraxanthine for Cognitive Improvement in Adults With ADHD and ASD

NCT07189442

Attention Deficit Hyperactivity Disorder (ADHD)Autism Spectrum Disorder (ASD)

View study

NOT_YET_RECRUITINGNA

Effects of Probiotics on the Gut-brain Axis in Children

NCT07459699

Attention Deficit Hyperactivity Disorder (ADHD)

View study

COMPLETED

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 12, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in England

Inclusion Criteria

Exclusion Criteria

L-theanine and Paraxanthine for Cognitive Improvement in Adults With ADHD and ASD

Effects of Probiotics on the Gut-brain Axis in Children

Neuro-Nutrition to Support Physiological Function and Cognitive Skills in People With Down Syndrome, Autism Spectrum Disorder, and ADHD

PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder

Internet-Based Behavioural Parent Training Intervention for Children With Attention Deficit/Hyperactivity Disorder

Brain Activity in Adults With ADHD During Neuropsychological Tasks